Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. KuKuruga
Mark A. KuKuruga
Center for Biologics Evaluation and Research
Nivolumab
Granzyme B
Cytokine
IL-2 receptor
T cell
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Functional heterogeneity of IFN-γ-licensed mesenchymal stromal cell immunosuppressive capacity on biomaterials.
2021
Proceedings of the National Academy of Sciences of the United States of America
Brian J Kwee
Johnny Lam
Adovi Akue
Mark A. KuKuruga
Kunyu Zhang
Luo Gu
Kyung E. Sung
Show All
Source
Cite
Save
Citations (0)
IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses.
2021
International Journal of Molecular Sciences
Taylor A. Harper
Silvia M. Bacot
Christie Jane Fennell
Rebecca L. Matthews
Christina Zhu
Peng Yue
Alexander Benton
Devira Friedman
Adovi Akue
Mark A. KuKuruga
Shiowjen Lee
Tao Wang
Gerald M. Feldman
Show All
Source
Cite
Save
Citations (0)
Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy.
2020
International Journal of Molecular Sciences
Silvia M. Bacot
Taylor A. Harper
Rebecca L. Matthews
Christie Jane Fennell
Adovi Akue
Mark A. KuKuruga
Shiowjen Lee
Tao Wang
Gerald M. Feldman
Show All
Source
Cite
Save
Citations (3)
1